A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Clinical trial NCT01709084 · COMPLETED

Trial details

NCT number: NCT01709084
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus-type 1 Infection

Start date: 2013-10-02
Primary completion: 2015-10-22
Enrollment: 426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.